氨溴索治疗慢性阻塞性肺疾病的临床疗效观察被引量：5

导出

摘要目的探讨氨溴索(沐舒坦)在慢性阻塞性肺疾病(COPD)急性加重期的治疗效果。方法COPD急性加重期患者60例,随机分为对照组和治疗组,在进行抗感染、平喘、糖皮质激素等常规药物治疗基础上,治疗组每天给予沐舒坦60mg,分2次静脉滴注。结果对照组总有效率67%,治疗组总有效率87%,两组疗效比较差异有统计学意义(P<0.05),两组临床缓解所需平均时间比较,差异有统计学意义(P<0.05)。结论沐舒坦用于COPD急性加重期疗效显著。

作者陈晓萍陈春生方琪

机构地区衢州市人民医院呼吸内科

出处《中国基层医药》 CAS 2006年第5期831-831,共1页 Chinese Journal of Primary Medicine and Pharmacy

关键词氨溴索肺疾病慢性阻塞性

分类号 R563.9 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献3

1李春,李善群,白春学,洪群英,刘伟,聂莉,张志凤.沐舒坦治疗慢性阻塞性肺病的临床疗效[J].中国临床医学,2003,10(3):409-411. 被引量：23
2Nowak D.Antioxidative features of ambroxol:usefulnes in COPD.Pneumonol Alergol Pol,2001,69 (9-10):590-593.
3朱科明,邓小明.沐舒坦对呼吸系统的保护作用及机制[J].上海医学,2000,23(10):637-639. 被引量：336

二级参考文献15

1[1]Gillissen A, Nowak D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. Respir Med, 1998, 92:609-623.
2[2]Teramoto S, Suzuki M, Ohga E, et al. Effects of ambroxol on spontaneous or stimulated generation of reactive oxygen species by bronchoalveolar lavage cells harvested from patients with or with-out chronic obstructive pulmonary diseases. Pharmacology,1999, 59:135-141.
3[3]Gillissen A, Bartling A, Schoen S, et al. Antioxidant function of ambroxol in mononuclear and polymorphonuclear cells in vitro. Lung, 1997, 175:235-242.
4[4]Park NH, Han ES, Lee CS, et al. The inhibitory effect of ambroxol on respiratory burst, de granulation and cytosolic Ca2+ change in degraded immunoglobulin G-activated neutrophils. Pharmacol Toxicol, 1999, 84: 81-87.
5[5]Pfeifer S, Zissel G, Kienast K, et al. Reduction of cytokine release of blood and bronchoalveolar mononuclear cells by ambroxol. EurJ Med Res, 1997, 2:129-132.
6[6]Stettner S, Ledwozyw A. The effect of Ambroxol on bleomycininduced changes in phospholipid composition of rat lung surfactant. Acta Physiol Hung, 1995, 83:181-187.
7[7]Mira E, Benazzo M, De Paoli F, et al. Surfactants of the air-ways. Critical review and personal research. Acta Otorhinolaryngol Ital, 1997, 17(1 Suppl 56):3-16.
8[8]Nemcekova E, Nosalova G, Franova S. Ambroxol and protective reflexes of the respiratory tract. Bratisl Lek Listy, 1998, 99:111-115.
9[9]Tyrakowski T, Greczko Ⅰ, Sedlaczek A, et al. Electrophysiological investigation of the effects of ambroxol on the transepithelial Na + ion transport pathway in airways. Pol J Pharmacol,1998, 50:31-38.
10[10]Tyrakowski T, Sedlaczek A, Greczko Ⅰ, et al. Ambroxol effect on transepithelial electrical potential difference of isolated tracheal wall. Pol J Pharmacol, 1997, 49:53-58.